Practices can increase their business through memberships, patient financing, and mobile rewardsRead more...
The Boston-based VC firm may shift from high-cost pharma to IT and Internet plays.Highland Capital has closed its eighth fund, worth $400 million. The firm plans to use Highland Capital Partners VIII Limited Partnership to fuel investments in early through growth stage companies in healthcare, internet & digital media and technology companies.
This fund is half the size of its $800 million Fund VII, raised in 2006, a reflection of leaner times, but also of continued confidence on the part of LP’s. The company has done well in recent years, helping 90 of its 200+ companies to get acquired or go public. Some of the firm’s recent successes include Conor Medsystems (IPO/acquired by Johnson & Johnson), lululemon athletica (Nasdaq: LULU), Starent Networks (Nasdaq: STAR) and VistaPrint (Nasdaq: VPRT).
Based in Boston, Highland has had a strong showing of pharmaceutical startups, but general partner Bob Higgins tells PE Hub that the firm will now be “more cautious on deals with high capital commitments,” which will likely mean shifting to lower-cost digital media and IT sectors.
Support VatorNews by Donating
Read more from our "Trends and news" series
The initiative will monitor patients hospitalized for bone marrow transplant and hematology as wellRead more...
The company will use the funding to mass produce its “peel & stick” microarray technologyRead more...
Related Companies, Investors, and Entrepreneurs
Joined Vator onSince 1988, HCP has taken a sector focused and stage diversified approach to investing in exceptional companies. We invest in seed, early, and growth stage companies in the IT, communications, healthcare, and consumer / retail markets.